News

Analyst Perspectives on Integral Ad Science: A Thorough Review

Analyst Perspectives on Integral Ad Science: A Thorough Review

Insights into Integral Ad Science Holding Corp's Analyst Ratings

Integral Ad Science Holding Corp (NASDAQ: IAS) has recently garnered attention from a group of five analysts, who have provided various ratings and insights reflecting different outlooks on the company. In the evolving landscape of digital advertising, the expert evaluations range widely, showcasing the company's market positioning and potential growth trajectory.

Understanding the Analyst Ratings: A Detailed Overview

Analysts play a critical role in the financial ecosystem by offering updated perspectives on stock performance. This section summarizes the actions taken by leading analysts and their evaluations regarding Integral Ad Science Holding Corp.

Analyst Actions and Ratings

As the market fluctuates, analysts adjust their ratings based on the latest data and company performance. The recent evaluations reveal some key points about Integral Ad Science, demonstrating a mix of cautious optimism:

  • Mark Kelley (Stifel): Lowered rating to Hold with a target price of $10.30, down from $14.00.
  • Vikram Kesavabhotla (Baird): Raised rating to Neutral with a price target of $10.30, up from $9.00.
  • Andrew Marok (Raymond James): Reduced rating to Outperform, adjusting the target to $11.00 from $13.00.
  • Raimo Lenschow (Barclays): Increased rating to Equal-Weight with a price target raised to $10.00 from $9.00.
  • Mark Kelley (Stifel): Furthermore, adjusted his stance to Buy, forecasting a target of $14.00, reflecting a more bullish outlook.

This range of adjustments illustrates the analysts' responsiveness to market conditions and company performance, indicating varying levels of confidence.

Price Targets and Market Trends

Analysts have identified an average 12-month price target for Integral Ad Science at around $11.12, showing a high estimate of $14.00 and a low estimate of $10.00. Notably, this average is approximately 4.14% lower than the previous average of $11.60, implying slight concern over future performance. Analysts’ price targets serve as indicators for potential investors, providing insights into expected future value based on market analysis.

Integral Ad Science Holding Corp: Company Profile

Integral Ad Science Holding Corp is recognized for its innovative digital advertising verification solutions. Utilizing advanced cloud-based technology, it ensures accurate measurement and verification across multiple devices and advertising formats, such as video and mobile. Notably, the majority of the company’s revenue stem from operations in North America, positioning it well within the thriving digital advertising sector.

Financial Insights: Key Metrics

Integral Ad Science’s financial performance offers valuable insights for investors:

  • Market Capitalization: The company is viewed as smaller compared to industry peers, potentially impacting its growth prospects and market perceptions.
  • Revenue Growth: Recently reported a robust revenue growth of 15.66%, marking a notable performance compared to industry benchmarks.
  • Net Margin: The company exhibits an impressive net margin of 11.0%, reflecting strong profitability management.
  • Return on Equity (ROE): Integral Ad Science displays a favorable ROE of 1.56%, indicating effective capital utilization.
  • Return on Assets (ROA): With an ROA of 1.42%, the company efficiently leverages its assets for growth.
  • Debt Management: A low debt-to-equity ratio of 0.03 signifies the company's prudent approach to managing liabilities.

The financial strength displayed by Integral Ad Science allows it to navigate market challenges effectively, reinforcing its position in the advertising technology space.

Why Analyst Ratings Matter

Understanding analyst ratings is crucial for interpreting stock performance. Analysts provide insights based on projected revenue streams and the overall market landscape. Through research and direct communications, they yield forecasts that shape investor expectations.

It’s important to recognize that while analysts possess expertise, their projections stem from analysis of data and financial trends. Their insights offer a roadmap for potential investors, aligning with the principles of informed investment strategies.

Frequently Asked Questions

What is Integral Ad Science Holding Corp known for?

Integral Ad Science Holding Corp specializes in digital advertising verification, ensuring accurate measurement across various devices and formats.

How have analysts rated Integral Ad Science recently?

Recent analyst ratings for Integral Ad Science show a mix of Hold, Neutral, and Buy recommendations, reflecting varied confidence levels among professionals.

What is the current average price target for IAS?

The average 12-month price target for Integral Ad Science is approximately $11.12, with estimates ranging from $10.00 to $14.00.

What financial metrics highlight Integral Ad Science's performance?

The company showcases a revenue growth of 15.66%, a net margin of 11.0%, and a low debt-to-equity ratio of 0.03, showcasing solid financial health.

Why should investors consider analyst reports?

Analyst reports provide vital insights into predicted market trends and stock performance, aiding investors in making informed decisions about their investments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Diwali Celebration in Chicago Honors Indian Community

Updated Category News Views 48

Chicago's Diwali Tribute: Music, Dance, and Diversity Talk about spreading the glow! On November 13, 2026, Cook County Treasurer Maria Pappas is gearing up to throw a Diwali bash that'll light up Chicago's cultural landscape. Alongside Indian Consul General Dr. M. Anand Prakash, she's orchestrating a vibrant affair designed to spotlight Indian American community leaders...

Continue Reading
Funding Fuels LCH2's Vision for Clean Energy Campus

Updated Category News Views 150

Money Talks: LCH2 Scores Big Again Just when you think it's all talk, they pony up another million bucks. The Lewis County Hydrogen Alliance, otherwise known as LCH2, didn't stop with a decent $400k earmark. Nope, they just went ahead and snagged an additional $1 million from TransAlta Centralia. This ain't chump change—it brings their total grant pile to a solid $1.4...

Continue Reading
Natura's 3Q26 Performance: Navigating Bottlenecks and Potential

Updated Category News Views 73

Unexpected Performance Amidst Challenging Circumstances I'll tell you, navigating through operational bottlenecks is no small feat, but Natura seems to be brewing its own survival recipe. They reported a net income of BRL 49 million in the third quarter of 2026, clawing back from a net loss of BRL 119 million in the previous year. That's no magic trick; it's a reflection...

Continue Reading
CytoSorbents Hits Financial Milestone in Q3 2026

Updated Category News Views 52

CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...

Continue Reading
Ani Huang: NAHR Fellow Elevates HR Leadership Standards

Updated Category News Views 64

Spotlight on Ani Huang's HR Leadership In a world where corporate strategies and workforce dynamics continually evolve, Ani Huang's ascent to Fellow of the National Academy of Human Resources (NAHR) signals a pivotal recognition. It's not just another pat on the back; it's a validation of a career steered by determination, expertise, and a knack for navigating the tangled...

Continue Reading
K-Jeonnam Gim Debuts on Amazon: Korean Seaweed Arrives

Updated Category News Views 13

Korean Seaweed Ventures to the US Market Alright, folks, here's a twist for your snack drawer—Korean seaweed making waves right on Amazon's virtual shelves! Shinan 1004 Seaweed Co. is shaking things up with their brand spankin' new K-Jeonnam Gim. This ain't just any old sea greens we're talking about. We're dealing with crispy, roasted sheets bursting with savory, nutty...

Continue Reading
DeFi Tech Q3 2026: Navigating Cash Strong Waters

Updated Category News Views 48

DeFi Technologies: Holding Steady as Markets Sway DeFi Technologies Inc. has just thrown its quarterly earnings into the ring. With $18.3 million in revenue and a net income of $22.3 million, this digital asset dynamo is showing signs of resilience, even as the financial seas continue their wild dance. For those of us watching the NASDAQ:DEFT like hawks, these figures...

Continue Reading
Health In Tech's Rocky Q3: Navigating Losses and Opportunities

Updated Category News Views 89

Signs of Optimism Amidst Financial Struggles Health In Tech is wading through the choppy waters of its Q3 2026 financial results—revenue came in at $6.6 million, down from $8.5 million the previous year. Seems like their investments are all geared up, but the sails aren’t quite catching wind yet. That said, their contracted revenue strutted to $32.7 million for the...

Continue Reading
Aviation Expo Draws Crowds, Revitalizing Future Pilots

Updated Category News Views 108

Youth Flock to Aviation's Future at Rider Jet Center On a crisp November day in Hagerstown, Maryland, the Rider Jet Center became a hive of ambition and dreams as the 20th Aviation Education & Career Expo unfolded. The whole shebang kicked off like an airport on a holiday weekend, bustling and packed. Over 1,100 students—full of questions, hopes, and the typical teen...

Continue Reading
OI Investors Crack Down: Class Action Filing Looms

Updated Category News Views 53

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Continue Reading

Top 5 Most Recently Viewed Articles

Westhaven Gold Announces Leadership Changes and Operations Update

Updated Category News Views 329

Westhaven Gold Corporate Update VANCOUVER, British Columbia — Westhaven Gold Corp. (TSX-V: WHN) has recently announced a significant transition with the departure of Sean Thompson, the Vice President of Corporate Development & Investor Relations. This change marks a new chapter for the company as it continues to focus on its exploration and development activities....

Continue Reading
TerSera Discusses Game-Changing Findings on Goserelin for Breast Cancer

Updated Category News Views 122

TerSera Therapeutics made waves back in 2024 when it presented new data on goserelin, a drug that's been a game-changer for managing breast cancer, especially in younger patients. This wasn't just some routine announcement; it dropped at a major oncology symposium focused on quality care. You know how the market loves buzz around innovative treatments, and this one had...

Continue Reading
The Influence of Corporate Earnings on Stock Valuations

Updated Category Stocks Views 371

Introduction to the Link Between Corporate Earnings and Stock Valuations The important and significant connection between earnings and stock prices is often a concern for shareholders, analysts, and the economy. Corporate earnings are also known as the bottom line, net income, or profit and reflect a business entity’s financial status over a certain period. While on the...

Continue Reading
Hyster-Yale Reports Q3 2024 Financial Performance and Insights

Updated Category News Views 110

Financial Overview for Q3 2024 Hyster-Yale, Inc. (NYSE: HY) has reported solid financial results for Q3 2024, showcasing the company's resilience in navigating seasonal fluctuations. Despite the third quarter typically being slower, Hyster-Yale executed well, achieving a cash generation of $70 million from operations. Highlights from Q3 2024 The Q3 2024 financial...

Continue Reading
Time2Play Teams with Fabrizio Romano to Elevate Soccer

Updated Category News Views 13

Bringing European Soccer Insight to American Fans Suddenly we're talking soccer in the U.S. in a way that's making heads spin. It ain't like the old days when only a small bunch tuned in. Now, with Fabrizio Romano, the kingpin of transfer tidbits, hopping onboard Time2play, there's a different energy afoot. It's about time American fans get the scoop the Europeans have...

Continue Reading